Menu
close

We are a team of medical experts.

Our team brings together experts from the fields 
of medicine, pharmacy, food chemistry, biology, logistics, politics and law. What binds us together 
is our common goal: “Unlocking the health benefits 
of cannabinoids.”
Our Purpose

Our Company

At Sanity Group, we have a clear goal: Unlocking the health benefits of cannabinoids. To achieve this ambitious goal, we live a corporate culture that balances high performance with continuous personal development. Our values guide both our behavior and our decision-making. They define the standard of quality for all the products we develop, how we talk to customers, who we hire and how we work with our colleagues.

If you want to learn more and become part of the European cannabis revolution, we invite you to take a look at our careers page!
Careers
It’s important to understand the full potential of the plant – that’s what we’re working for, to bring cannabis back to the center of European society.”
Finn Hänsel
Managing director & Founder

Medical Advisory Board

The Medical Advisory Board comprises renowned experts in pain therapy, palliative medicine, neurology and pharmacology. We are united by the goal to better understand the therapy and needs of our patients and to establish an individualized therapy within the framework of cross-sector treatment concepts with cannabis. Another focus of our work is to detect medical evidence, the reduction of bureaucracy, advanced training for doctors and the development of further dosage forms.

Prof. Dr. Kirsten 
Müller-Vahl

Prof. Dr. Kirsten Müller-Vahl is Professor of Psychiatry at the Department of Psychiatry, Social Psychiatry and Psychotherapy at 
the Hannover Medical School (MHH) in Germany. She is a specialist in neurology and adult psychiatry. 
For more than 20 years, she has been involved in research on the effects of cannabinoids on humans and is a founding member of the International Association for Cannabinoid Medicines (IACM).

Prof. Dr. Thomas Herdegen

Prof. Dr. Thomas Herdegen is a professor at Kiel University (CAU) and heads the Neuropharmacology Section at the Institute for Experimental and Clinical Pharmacology. Prof. Dr. Herdegen’s research interests include the intersection of pain at the nervous system. He is a pharmacologist and researches methods against neurodegenerative diseases.

Prof. Dr. Dr. Joachim Nadstawek

Prof. Dr. Dr. Joachim Nadstawek, specialist in anesthesia at the Schmerzzentrum Jankerklinik in Bonn. Prof Nadstawek has been the chairman of the Professional Association of Doctors and Psychological Psychotherapists in Pain and Palliative Medicine Germany eV (BVSD) since May 2011. As chairman, Prof. Nadstawek has been politically and medically very successful in improving the pain therapy care for patients for almost 10 years Germany.

Political Advisory Board

Our Political Advisory Board comprises renowned political experts and healthcare professionals who provide strategic guidance and advice to support Sanity Group to meet its mission and objectives. The outstanding experience and the commitment of the members of the Political Advisory Board are crucial to outlining a long-term vision of the activities of Sanity Group.

Dr. Mark Dankhoff

Dr. Mark Dankhoff is a specialist in general medicine, nutritional medicine, diabetes primary care and hypertensiology, trained in addiction medicine and an expert in the treatment of cardiovascular risk factors. Among other things, he worked as a consulting doctor in the board department for health services research at a large German health insurance company. He is currently Head Physician and CEO of a specialist clinic for children and adolescents.

Prof. Dr. Dr. Alexander Görlach

Alexander Görlach is a professor of ethics and theology at the University of Lüneburg, who previously served in various positions at Harvard University (USA) and Cambridge University (UK). He is the founder of the debate magazine ‘The European’, which he also ran as its editor in chief from 2009 until 2015. Today Mr. Görlach is an op-ed contributor to the New York Times and Neue Zürcher Zeitung. He is also a columnist to Wirtschaftswoche and Deutsche Welle.

Uwe Laue

Uwe Laue is an expert on the German healthcare system and its health insurance landscape. He was chairman of the Private Health Insurance Association (PKV) from 2013 to 2019 as well as chairman of the management board of the Debeka Insurance Group from 2002 to 2018, to which he was appointed in 1998. Furthermore, he served as a member of the Presidential Council of the German Insurance Association (GDV) from 2013 to 2019.

Our Investors